Red Queen Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2021-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://redqueentx.com
Clinical Trial to Evaluate the Safety of RQ-01 in SARS-CoV-2 Positive Subjects
Phase 1
Completed
- Conditions
- SARS CoV 2 InfectionInfectious DiseaseSymptomatic COVID-19 Infection Laboratory-ConfirmedCOVID-19
- Interventions
- Combination Product: RQ-001Other: Placebo
- First Posted Date
- 2023-10-02
- Last Posted Date
- 2024-01-11
- Lead Sponsor
- Red Queen Therapeutics, Inc.
- Target Recruit Count
- 66
- Registration Number
- NCT06063330
- Locations
- 🇺🇸
Florida International Medical Research, Miami, Florida, United States
🇺🇸Zenos Clinical Research, Dallas, Texas, United States
🇺🇸University of Maryland School of Medicine, Baltimore, Maryland, United States
© Copyright 2025. All Rights Reserved by MedPath